Related trials
ZEST AMI (vs SES), 2009 - zotarolimus ES vs sirolimus ES
TRIANA, 2009 - primary ballon angioplasty vs tenecteplase
DEBATER (SES vs BMS), 2009 - sirolimus ES vs bare-metal stent
NORDISTEMI, 2009 - thrombolysis + angioplasty vs immediate thrombolysis
Juwana, 2009 - sirolimus ES vs paclitaxel ES
ZEST AMI (vs PES), 2009 - zotarolimus ES vs paclitaxel ES
PASEO, 2009 - drug ES vs bare-metal stent
CARESS, 2008 - thrombolysis + angioplasty vs immediate thrombolysis
HORIZONS-AMI Stent, 2008 - paclitaxel ES vs bare-metal stent
MISSION, 2008 - sirolimus ES vs bare-metal stent
DEDICATION, 2008 - drug ES vs bare-metal stent
Díaz de la Llera, 2007 - sirolimus ES vs bare-metal stent
SESAMI, 2007 - sirolimus ES vs bare-metal stent
TYPHOON, 2006 - sirolimus ES vs bare-metal stent
PROSIT, 2006 - sirolimus ES vs paclitaxel ES
HAAMU-STENT, 2006 - paclitaxel ES vs bare-metal stent
PASSION, 2006 - paclitaxel ES vs bare-metal stent
WEST, 2006 - systematic PCI (+stent) vs no systematic PCI
ZWOLLE 6, 2005 - primary stenting vs ballon angioplasty
CAPITAL AMI, 2005 - systematic PCI (+stent) vs no systematic PCI
senior PAMI, 2005 - primary PCI vs thrombolytic therapy
CAPITAL AMI, 2005 - thrombolysis + angioplasty vs immediate thrombolysis
Di Lorenzo et al., 2005 - sirolimus ES vs paclitaxel ES
GRACIA-1, 2004 - systematic PCI (+stent) vs no systematic PCI
MERLIN (Sutton), 2004 - immediate systematic ballon angioplastyte vs no immediate angioplasty
See also:
All acute myocardial infarction clinical trials
All clinical trials of PCI
All clinical trials of primary ballon angioplasty
|
|
Treatments
| Studied treatment |
primary PTCA
|
| Control treatment |
accelerated t-PA 90 min (15 mg IV bolus followed by an infusion of 0.75 mg/kg over 30min not to exceed 50mg, and then 0.5 mg/kg over the next 60min not to exceed 35mg for a total maximun of 100mg)
|
| Concomittant treatment |
aspirin (135-325mg/d) heparin in the angioplasty group: bolus of 10000UI followed by 1000IU/h for 48h, in the t-PA group: 1000UI/h for 38h |
| Treatments description |
|
Patients
| Patients |
patients with anterior AMI |
| Inclusion criteria |
anterior myocardial infraction, <5h from the onset of pain, |
| Baseline characteristics |
| anterior MI |
100% |
| inferior MI |
0% |
| Delay to treatment (PTCA vs thr) |
15 min |
| Diabetes |
NA |
| Previous MI |
NA |
| Killip>=2 |
NA |
| Mean EF |
NA |
| % female |
NA |
| mean age |
NA |
|
Method and design
| Randomized effectives |
95 / 94 (studied vs. control) |
| Design |
Parallel groups |
| Blinding |
open |
| Follow-up duration |
30 d |
| Lost to follow-up |
ND |
| Number of centre |
single center |
| Geographic area |
Spain |
| Hypothesis |
Superiority |
| Withdrawals (T1/T0) |
ND / |
Results
No results available for this trial
- no clinical endpoint reported
Reference(s)
-
García E, Elízaga J, Pérez-Castellano N, Serrano JA, Soriano J, Abeytua M, Botas J, Rubio R, López de Sá E, López-Sendón JL, Delcán JL.
Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction..
J Am Coll Cardiol 1999;33:605-11
Pubmed
|
Hubmed
| Fulltext
|